/TD>
|
|
Links
Home FDA Information |
AloxiThis page contains recent news articles, when available, and an overview of Aloxi (palonosetron)Recent news articles mentioning AloxiHELSINN HEALTHCARE SA Announces Patent Extension for Aloxi(R ... - Feb 15, 2007 Drug Newswire (press release), Aloxi(R) is approved by the US Food and Drug Administration (FDA) for the prevention of acute nausea and vomiting associated with initial and repeat courses MGI Pharma Holds Off on Aloxi Outlook - Feb 7, 2007 Forbes, Cancer drug developer MGI Pharma Inc. said Wednesday it won't provide 2007 sales guidance for its Aloxi medication due to changes in the MGI Pharma receives patent extension on nausea drug - Feb 13, 2007 Pharmaceutical Business Review MGI Pharma and its partner Helsinn Healthcare have said that a patent term extension has been granted covering Aloxi injection in the US. MGI PHARMA Reports Fourth Quarter and Full Year 2006 Financial Results - Feb 8, 2007 PharmaLive.com (press release), ..."We announced positive phase 3 results for Aloxi in post operative nausea and vomiting and for the first of two pivotal trials of Aquavan. Correction: MGI Pharma Earnings Story - Feb 8, 2007 Forbes, 7 story about MGI Pharma Inc.'s fourth-quarter results, The Associated Press reported erroneously that a generic version of its Aloxi drug, Earnings, outlook lift MGI stock - Feb 9, 2007 Pioneer Press, Analysts have feared that sales of the company's drug Aloxi, which generated more than half of MGI Pharma's revenue in 2006, would be hurt by the Company roundup - Feb 13, 2007 Minneapolis Star Tribune (subscription), Aloxi is approved by the Food and Drug Administration for prevention of nausea and vomiting associated with cancer chemotherapy. Navarre Corp., New Hope, MGI Pharma anti-nausea drug gets patent extension - Feb 13, 2007 Reuters O: Quote, Profile , Research) and Swiss drug company Helsinn Healthcare SA on Tuesday said the anti-nausea drug Aloxi received a five-year US patent Correction: MGI Pharma Outlook Story - Feb 8, 2007 Forbes, 7 story about MGI Pharma Inc.'s outlook, The Associated Press reported erroneously that a generic version of its anti-nausea treatment Aloxi became MGI Pharma Narrows 4th-Quarter Loss - Feb 7, 2007 Forbes, Cancer drug developer MGI Pharma Inc. reported a narrower fourth-quarter loss on Wednesday despite declining sales of its Aloxi anti-nausea drug. UPDATE 1-MGI Pharma loss narrows, blood disorder drug helps - Feb 7, 2007 Reuters Quarterly US sales of Aloxi, MGI Pharma's biggest product which is used to prevent chemotherapy-related nausea and vomiting, fell to $49.6 million from $67 MGI Pharma narrows 4th-quarter loss - Feb 7, 2007 ABCmoney.co.uk, MINNEAPOLIS (AFX) - Cancer drug developer MGI Pharma Inc. reported a narrower fourth-quarter loss on Wednesday despite declining sales of its Aloxi MGI Pharma loss narrows - Feb 7, 2007 Reuters Dacogen cancer drug offset declining revenue from nausea treatment Aloxi, which is now facing competition from a generic form of a similar medicine. MGI Pharma to Present at the 2007 Merrill Lynch Global ... - Feb 1, 2007 PharmaLive.com (press release), MGI PHARMA markets Aloxi(R) (palonosetron hydrochloride) Injection, Dacogen(TM) (decitabine) for Injection and Gliadel(R) Wafer (polifeprosan 20 with MGI PHARMA to Present at the 2007 Merrill Lynch Global ... - Jan 31, 2007 dBusinessNews Minneapolis (press release), MGI PHARMA markets Aloxi® (palonosetron hydrochloride) Injection, Dacogen™ (decitabine) for Injection and Gliadel® Wafer (polifeprosan 20 with carmustine Biotech Day In Review: Another Setback for Acomplia from Sanofi ... - Feb 14, 2007 Seeking Alpha, MGI Pharma (MOGN) and Helsinn Healthcare SA of Switzerland received a five-year extension of their patent for Aloxi, a treatment for nausea and vomiting (PRN) - Crdentia Completes Private Placements of Common Stock ... - Feb 13, 2007 Bolsamania.com, ...(PRN) - HELSINN HEALTHCARE SA Announces Patent Extension for Aloxi(R) Injection in the US ... [+]. (PRN) - Rawlings to Unveil Ballot of Top 50 All-Time Other uses for Aloxi [MedMaster Patient Drug Information database] Before using darbepoetin alfa,
|